Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation

Journal of Medical Virology

Volumn 86, Issue 5, 2014, Pages 812-819

  Ogunjimi, Benson ^a,b   Theeten, Heidi ^a   Hens, Niel ^a,b   Beutels, Philippe ^a,c  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

CMV; Herpes zoster; Immunosenescence; Measles; Parvovirus; Reactivation

Indexed keywords

ADOLESCENT; ADULT; AGED; AGING; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; CELL COUNT; CHILD; CYTOMEGALOVIRUS INFECTION; FEMALE; GROUPS BY AGE; HUMAN; HUMAN PARVOVIRUS B19; INFANT; MAJOR CLINICAL STUDY; MALE; MEASLES VIRUS; MIDDLE AGED; MULTIPLE LINEAR REGRESSION ANALYSIS; PRESCHOOL CHILD; SCHOOL CHILD; SEROLOGY; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION; YOUNG ADULT;

CYTOMEGALOVIRUS; HERPES ZOSTER; HUMAN HERPESVIRUS 3; MEASLES VIRUS; PARVOVIRUS;

CMV; HERPES ZOSTER; IMMUNOSENESCENCE; MEASLES; PARVOVIRUS; REACTIVATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGING; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; INFANT; MALE; MIDDLE AGED; VIRUS ACTIVATION; YOUNG ADULT;

EID: 84895924285     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23749     Document Type: Article

References (30)

1. Aberle JH, Puchhammer-Stockl E. 2012. Age-dependent increase of memory B cell response to cytomegalovirus in healthy adults. Exp Gerontol 47:654-657.
2. Almanzar G, Schwaiger S, Jenewein B, Keller M, Herndler-Brandstetter D, Wurzner R, Schonitzer D, Grubeck-Loebenstein B. 2005. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol 79:3675-3683.
3. Amanna IJ, Slifka MK. 2010. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol Rev 236:125-138.
4. Amanna IJ, Carlson NE, Slifka MK. 2007. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 357:1903-1915.
5. Andraud M, Lejeune O, Musoro JZ, Ogunjimi B, Beutels P, Hens N. 2012. Living on three time scales: The dynamics of plasma cell and antibody populations illustrated for hepatitis a virus. PLoS Comput Biol 8:e1002418.
6. Andrews N, Tischer A, Siedler A, Pebody RG, Barbara C, Cotter S, Duks A, Gacheva N, Bohumir K, Johansen K, Mossong J, Ory F, Prosenc K, Slacikova M, Theeten H, Zarvou M, Pistol A, Bartha K, Cohen D, Backhouse J, Griskevicius A. 2008. Towards elimination: Measles susceptibility in Australia and 17 European countries. Bull World Health Organ 86:197-204.
7. Beutels P, Van Damme P, Van Casteren V, Gay NJ, De Schrijver K, Meheus A. 2002. The difficult quest for data on "vanishing" vaccine-preventable infections in Europe: The case of measles in Flanders (Belgium). Vaccine 20:3551-3559.
8. Bilcke J, Ogunjimi B, Marais C, de Smet F, Callens M, Callaert K, van Kerschaver E, Ramet J, van Damme P, Beutels P. 2012. The health and economic burden of chickenpox and herpes zoster in Belgium. Epidemiol Infect 140:2096-2109.
9. Chidrawar S, Khan N, Wei W, McLarnon A, Smith N, Nayak L, Moss P. 2009. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin Exp Immunol 155:423-432.
10. Cohrs RJ, Mehta SK, Schmid DS, Gilden DH, Pierson DL. 2008. Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts. J Med Virol 80:1116-1122.
11. Derhovanessian E, Maier AB, Beck R, Jahn G, Hahnel K, Slagboom PE, de Craen AJ, Westendorp RG, Pawelec G. 2010. Hallmark features of immunosenescence are absent in familial longevity. J Immunol 185:4618-4624.
12. Derhovanessian E, Maier AB, Hahnel K, Beck R, de Craen AJ, Slagboom EP, Westendorp RG, Pawelec G. 2011. Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans. J Gen Virol 92:2746-2756.
13. Fletcher JM, Vukmanovic-Stejic M, Dunne PJ, Birch KE, Cook JE, Jackson SE, Salmon M, Rustin MH, Akbar AN. 2005. Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol 175:8218-8225.
14. Gillespie GM, Wills MR, Appay V, O'Callaghan C, Murphy M, Smith N, Sissons P, Rowland-Jones S, Bell JI, Moss PA. 2000. Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J Virol 74:8140-8150.
15. Goeyvaerts N, Hens N, Aerts M, Beutels P. 2011. Model structure analysis to estimate basic immunological processes and maternal risk for parvovirus B19. Biostatistics 12:283-302.
16. Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA. 2005. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 20:748-753.
17. Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ, Nayak L, Moss PA. 2002. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 169:1984-1992.
18. Khan N, Hislop A, Gudgeon N, Cobbold M, Khanna R, Nayak L, Rickinson AB, Moss PA. 2004. Herpesvirus-specific CD8 T cell immunity in old age: Cytomegalovirus impairs the response to a coresident EBV infection. J Immunol 173:7481-7489.
19. Kutner M, Nachtsheim CJ, Neter J, Li W. 2004. Applied linear statistical models, 5th edition. New York: McGraw-Hill. 1396 p.
20. Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan IS, Li DJ, Wang W, Keller PM, Shaw A, Silber JL, Schlienger K, Chalikonda I, Vessey SJ, Caulfield MJ. 2003. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis 188:1336-1344.
21. Liljeqvist JA, Tunback P, Norberg P. 2009. Asymptomatically shed recombinant herpes simplex virus type 1 strains detected in saliva. J Gen Virol 90:559-566.
22. Mehta SK, Stowe RP, Feiveson AH, Tyring SK, Pierson DL. 2000. Reactivation and shedding of cytomegalovirus in astronauts during spaceflight. J Infect Dis 182:1761-1764.
23. Miller AE. 1980. Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology 30:582-587.
24. Nagel MA, Choe A, Cohrs RJ, Traktinskiy I, Sorensen K, Mehta SK, Pierson DL, Tyring SK, Haitz K, DiGiorgio C, LaPolla W, Gilden D. 2011. Persistence of varicella zoster virus DNA in saliva after herpes zoster. J Infect Dis 204:820-824.
25. Ogunjimi B, Hens N, Goeyvaerts N, Aerts M, Van Damme P, Beutels P. 2009. Using empirical social contact data to model person to person infectious disease transmission: An illustration for varicella. Math Biosci 218:80-87.
26. Ogunjimi B, Smits E, Hens N, Hens A, Lenders K, Ieven M, Van Tendeloo V, Van Damme P, Beutels P. 2011. Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parents. Viral Immunol 24:151-157.
27. Stowe RP, Kozlova EV, Yetman DL, Walling DM, Goodwin JS, Glaser R. 2007. Chronic herpesvirus reactivation occurs in aging. Exp Gerontol 42:563-570.
28. Stowe RP, Peek MK, Cutchin MP, Goodwin JS. 2012. Reactivation of herpes simplex virus type 1 is associated with cytomegalovirus and age. J Med Virol 84:1797-1802.
29. Weinberg A, Zhang JH, Oxman MN, Johnson GR, Hayward AR, Caulfield MJ, Irwin MR, Clair J, Smith JG, Stanley H, Marchese RD, Harbecke R, Williams HM, Chan IS, Arbeit RD, Gershon AA, Schodel F, Morrison VA, Kauffman CA, Straus SE, Schmader KE, Davis LE, Levin MJ. 2009. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis 200:1068-1077.
30. Yan J, Greer JM, Hull R, O'Sullivan JD, Henderson RD, Read SJ, McCombe PA. 2010. The effect of ageing on human lymphocyte subsets: Comparison of males and females. Immun Ageing 7:4.